COMMUNIQUÉS West-GlobeNewswire

HTG Molecular Diagnostics Announces Pricing of Public Offering of Common Stock
19/01/2018
TUCSON, Ariz., Jan. 18, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM ) (HTG), a provider of instruments, reagents and services for molecular profiling applications, today announced the pricing [...]
UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares
19/01/2018
RA'ANANA, Israel and NEW YORK, Jan. 18, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN ), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with [...]
Diversicare to Present at the Noble Capital Markets’ Fourteenth Annual Investor Conference
18/01/2018
BRENTWOOD, Tenn., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Diversicare Healthcare, Inc. (Nasdaq: DVCR ), a premier operator of long-term care services, today announced that its President and Chief Executive Officer, Kelly Gill [...]
Reata Announces the Publication of Efficacy Data From the Beacon Study of Bardoxolone in Diabetic CKD in the American Journal of Nephrology
18/01/2018
IRVING, Texas, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA ) (“Reata” or “the Company”), a clinical-stage biopharmaceutical company, today announced the digital publication of an original [...]
CBMG Accelerates Cell Therapy Manufacturing with GE Healthcare’s New Start-to-Finish Solution
18/01/2018
GE supports CBMG in its aim to speed up manufacturing timelines for its CAR T-cell therapy clinical trials and future commercialization First GE Healthcare FlexFactory™ for cell therapy installation in the world [...]
TRACON Pharmaceuticals Reports Granting of Inducement Awards
18/01/2018
SAN DIEGO, Jan. 18, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON ), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]
Aeglea BioTherapeutics to Present Preclinical Data at 2018 Keystone Symposia Tumor Metabolism Conference
18/01/2018
AUSTIN, Texas, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE ), a biotechnology company committed to the discovery and development of engineered human enzyme therapeutics for patients with [...]
TiGenix: Transparency notification pursuant to Article 14 of the Law of May 2, 2007
18/01/2018
REGULATED INFORMATION PRESS RELEASE Transparency notification pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - January 18, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") [...]
109 Healthcare Groups Urge Congress to Immediately Reverse CMS Policy Linking Physician Payment Adjustments to Part B Drug Costs
18/01/2018
Washington, DC, Jan. 18, 2018 (GLOBE NEWSWIRE) -- More than 100 of the nation’s leading patient and provider organizations – including the American College of Rheumatology – are urging Congressional leaders to [...]
Phase 1b/2 Study of Margetuximab in Combination with Pembrolizumab Presented at 2018 ASCO Gastrointestinal Cancers Symposium
18/01/2018
Chemotherapy-free, immunotherapeutic combination evaluated 32% Overall response rate in second-line gastric cancer patients Well tolerated in dose escalation and expansion cohorts Rockville, MD, Jan. 18, 2018 (GLOBE [...]
Adherium Corporate Headquarters Opens in Silicon Valley
18/01/2018
SAN MATEO, Calif., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, today announced the opening of its corporate headquarters in San [...]
Sight-Restorative Eye Donations and Transplants in Colorado and Wyoming Break Records
18/01/2018
DENVER, Jan. 18, 2018 (GLOBE NEWSWIRE) -- The number of eye donations in Colorado and Wyoming, and the number of sight-restorative corneal transplants performed as a result, were at an all-time high in 2017. According [...]
NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2017 Financial Results Conference Call
18/01/2018
WALTHAM, Mass., Jan. 18, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO ) announced today that it plans to issue its fourth quarter and full year 2017 financial results before the opening of the market on [...]
Paratek Announces Pricing of Public Offering of Common Stock
18/01/2018
BOSTON, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon its expertise in [...]
Imaging3 Announces Formation of a Scientific Advisory Board
18/01/2018
BURBANK, Calif., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Imaging3, Inc. (OTCQB:IGNG), a development stage company targeting disruptive technologies in the medical imaging industry, announced today the formation of a [...]
FIT Biotech Oy: FIT Biotech's CEO to change - Erkki Pekkarinen appointed as a new CEO
18/01/2018
FIT Biotech Oy Company release January 18, 2018 at 4.05 pm EET FIT Biotech's CEO to change - Erkki Pekkarinen appointed as a new CEO The Board of Directors of FIT Biotech Oy (the "Company") has appointed Vice Chairman [...]
Rexahn Pharmaceuticals to Present at the American Society of Clinical Oncology Gastrointestinal Cancers (ASCO GI) 2018 Annual Meeting
18/01/2018
ROCKVILLE, Md., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, [...]
Lexington Completes IRB Submission in Preparation for Clinical Study
18/01/2018
VANCOUVER, British Columbia, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is pleased to announce it [...]
Clinical Genomics appoints Tadd Lazarus, M.D., as Chief Medical Officer
18/01/2018
BRIDGEWATER, N.J., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer diagnostic solutions and liquid biopsy tests, today announced the appointment of Tadd Lazarus, M.D., as Chief Medical [...]

Pages